Streetbeat News

Equity Actions

EFTR

eFFECTOR Therapeutics announced an $8.7 million registered direct offering priced at-the-market under Nasdaq rules.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 12:04 pm

COIN

QQQ

SPY

TSLA

YXT

US stock futures indicate a flat opening on Wednesday as uncertainty prevails ahead of the Federal Reserve's decision next week. Stocks ended slightly higher on Tuesday, with the Nasdaq Composite reaching its highest level since April 20, 2022. LPL Financial's Adam Turnquist advises caution, remaining neutral on equities. In premarket trading, SPY and QQQ ETFs edged up, while several companies, including COIN, YXT, and TSLA, saw premarket gains.

Portfolio Pulse from Shanthi Rexaline

June 07, 2023 | 11:34 am

CSIQ

Canadian Solar's subsidiary, CSI Solar, is set to be listed on the Shanghai Stock Exchange on June 9, 2023. This listing may impact Canadian Solar's stock (CSIQ) in the short term.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:21 am

ATNM

Actinium Pharma is set to join the Russell 2000 and Russell 3000 indexes, which could lead to increased visibility and investment in the company.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:07 am

SSTK

Shutterstock has announced a share repurchase program of up to $100 million, aiming to return value to shareholders and increase shareholder confidence.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:03 am

RHP

Ryman Hospitality Properties (RHP) has upsized its public offering to 3.85 million shares at $93.25 per share. The net proceeds will be contributed to RHP Hotel Properties, LP to fund a portion of the $800 million acquisition of JW Marriott San Antonio Hill Country Resort & Spa.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 9:48 am

COGT

Cogent Biosciences has priced its upsized public offering of 12.5 million shares at $12 per share, expecting to raise $150 million. The proceeds will be used for development, regulatory, and commercial preparation activities, as well as working capital and general corporate purposes.

Portfolio Pulse from Charles Gross

June 07, 2023 | 9:35 am

DAWN

Day One Biopharmaceuticals (NASDAQ:DAWN) has priced its underwritten public offering of 11,538,462 shares of common stock at $13.00 per share, expecting to raise approximately $150 million. The offering is set to close on June 9, 2023.

Portfolio Pulse from Charles Gross

June 07, 2023 | 9:29 am

NAMS

NewAmsterdam Pharma (NASDAQ:NAMS) has priced its secondary offering of 13,857,415 ordinary shares at $11.50 per share. The offering is expected to close on June 9, 2023, and the company will not receive any proceeds from it.

Portfolio Pulse from Charles Gross

June 07, 2023 | 9:19 am

MOND

Mondee Holdings Inc. (NASDAQ: MOND) has priced a secondary offering of 5.25 million shares at $10 per share on behalf of certain stockholders. The offering is expected to close on June 9, 2023. Mondee will not receive any proceeds from the offering. Morgan Stanley is the lead bookrunning manager.

Portfolio Pulse from Charles Gross

June 07, 2023 | 9:09 am